Louisiana has asked the Supreme Court to block the mailing of abortion pills. The state wants to halt access to mifepristone, a medication used to end early pregnancies.
The request follows a federal appeals court decision. That court temporarily blocked a Food and Drug Administration regulation that expanded access to the drug.
The FDA rule allowed mifepristone to be prescribed via telehealth and sent through the mail. This change significantly broadened the availability of medication abortion across the country.
Louisiana argues the regulation bypasses state laws. The state has some of the strictest abortion restrictions in the nation.
The appeals court ruling created a patchwork of enforcement. It effectively limits mail-order access to the drug in some states while leaving it available in others.
The Supreme Court now faces a critical decision. Its ruling will determine whether the FDA’s rule remains in place nationwide.
This case highlights ongoing legal battles over abortion access. It tests the balance between federal drug regulation and state authority.
Observers expect a quick ruling from the high court. The issue remains urgent as access to medication abortion continues to be a central political and legal flashpoint.
